Ajanta Pharma (BOM:532331) Scaled Net Operating Assets : N/A (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ajanta Pharma's operating assets for the quarter that ended in Mar. 2024 was ₹41,586 Mil. Ajanta Pharma's operating liabilities for the quarter that ended in Mar. 2024 was ₹10,358 Mil. Ajanta Pharma's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil. Therefore, Ajanta Pharma's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was N/A.

Ajanta Pharma Scaled Net Operating Assets Historical Data

The historical data trend for Ajanta Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Scaled Net Operating Assets Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.89

0.80

0.78

0.64

0.67

Ajanta Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ajanta Pharma's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ajanta Pharma's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Scaled Net Operating Assets falls into.

Ajanta Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ajanta Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(41585.5	-	10357.5)	/	46790.2
=	0.67

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	46383.9	-	4798.4
=	41585.5

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	10710.3	-	235.2	-	117.6
=	10357.5

Ajanta Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(41585.5	-	10357.5)	/	0
=	N/A

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	46383.9	-	4798.4
=	41585.5

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	10710.3	-	235.2	-	117.6
=	10357.5

Ajanta Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajanta Pharma (BOM:532331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

AJANTPHARM:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines